Preoperative hyperthermochemoradiotherapy for patients with rectal cancer

Masaki Mori, Keizo Sugimachi, Hiroyuki Matsuda, Shinji Ohno, Tetsuya Inoue, Masaaki Nagamatsu, Hiroyuki Kuwano

研究成果: ジャーナルへの寄稿記事

24 引用 (Scopus)

抄録

Preoperative hyperthermochemoradiotherapy (HCR therapy), consists of a combination of hyperthermia at 42 to 45°C for 40 minutes (2 times per week for two weeks), 5-fluorouracil (5-FU) intravenously (total, 1000 to 1750 mg), and a total of 30 Gy irradiation. The therapy was prescribed preoperatively most recently for 11 patients with rectal cancer. The authors used a radiofrequency system involving an endotract electrode with thermosensors for the hyperthermia. The effectiveness of preoperative HCR therapy was evaluated by irrigography, fiberscopy, and histopathologic findings in the resected specimens. Reduction in tumor size and amount was evident in all patients, with all modes of assessment. Histologically, no or only a few viable cancer cells were seen in the resected specimens in six patients, a small number of viable cancer cells in three, and a fair number of viable cancer cells in two patients; there were no complications. This method of treatment is expected to play an important role in the interdisciplinary treatment for rectal cancer.

元の言語英語
ページ(範囲)316-322
ページ数7
ジャーナルDiseases of the Colon & Rectum
32
発行部数4
DOI
出版物ステータス出版済み - 4 1 1989

Fingerprint

Rectal Neoplasms
Neoplasms
Fever
Therapeutics
Fluorouracil
Electrodes

All Science Journal Classification (ASJC) codes

  • Gastroenterology

これを引用

Mori, M., Sugimachi, K., Matsuda, H., Ohno, S., Inoue, T., Nagamatsu, M., & Kuwano, H. (1989). Preoperative hyperthermochemoradiotherapy for patients with rectal cancer. Diseases of the Colon & Rectum, 32(4), 316-322. https://doi.org/10.1007/BF02553487

Preoperative hyperthermochemoradiotherapy for patients with rectal cancer. / Mori, Masaki; Sugimachi, Keizo; Matsuda, Hiroyuki; Ohno, Shinji; Inoue, Tetsuya; Nagamatsu, Masaaki; Kuwano, Hiroyuki.

:: Diseases of the Colon & Rectum, 巻 32, 番号 4, 01.04.1989, p. 316-322.

研究成果: ジャーナルへの寄稿記事

Mori, M, Sugimachi, K, Matsuda, H, Ohno, S, Inoue, T, Nagamatsu, M & Kuwano, H 1989, 'Preoperative hyperthermochemoradiotherapy for patients with rectal cancer', Diseases of the Colon & Rectum, 巻. 32, 番号 4, pp. 316-322. https://doi.org/10.1007/BF02553487
Mori, Masaki ; Sugimachi, Keizo ; Matsuda, Hiroyuki ; Ohno, Shinji ; Inoue, Tetsuya ; Nagamatsu, Masaaki ; Kuwano, Hiroyuki. / Preoperative hyperthermochemoradiotherapy for patients with rectal cancer. :: Diseases of the Colon & Rectum. 1989 ; 巻 32, 番号 4. pp. 316-322.
@article{4f3b280f6f9f4c998b3ab1ab30bf271b,
title = "Preoperative hyperthermochemoradiotherapy for patients with rectal cancer",
abstract = "Preoperative hyperthermochemoradiotherapy (HCR therapy), consists of a combination of hyperthermia at 42 to 45°C for 40 minutes (2 times per week for two weeks), 5-fluorouracil (5-FU) intravenously (total, 1000 to 1750 mg), and a total of 30 Gy irradiation. The therapy was prescribed preoperatively most recently for 11 patients with rectal cancer. The authors used a radiofrequency system involving an endotract electrode with thermosensors for the hyperthermia. The effectiveness of preoperative HCR therapy was evaluated by irrigography, fiberscopy, and histopathologic findings in the resected specimens. Reduction in tumor size and amount was evident in all patients, with all modes of assessment. Histologically, no or only a few viable cancer cells were seen in the resected specimens in six patients, a small number of viable cancer cells in three, and a fair number of viable cancer cells in two patients; there were no complications. This method of treatment is expected to play an important role in the interdisciplinary treatment for rectal cancer.",
author = "Masaki Mori and Keizo Sugimachi and Hiroyuki Matsuda and Shinji Ohno and Tetsuya Inoue and Masaaki Nagamatsu and Hiroyuki Kuwano",
year = "1989",
month = "4",
day = "1",
doi = "10.1007/BF02553487",
language = "English",
volume = "32",
pages = "316--322",
journal = "Diseases of the Colon and Rectum",
issn = "0012-3706",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Preoperative hyperthermochemoradiotherapy for patients with rectal cancer

AU - Mori, Masaki

AU - Sugimachi, Keizo

AU - Matsuda, Hiroyuki

AU - Ohno, Shinji

AU - Inoue, Tetsuya

AU - Nagamatsu, Masaaki

AU - Kuwano, Hiroyuki

PY - 1989/4/1

Y1 - 1989/4/1

N2 - Preoperative hyperthermochemoradiotherapy (HCR therapy), consists of a combination of hyperthermia at 42 to 45°C for 40 minutes (2 times per week for two weeks), 5-fluorouracil (5-FU) intravenously (total, 1000 to 1750 mg), and a total of 30 Gy irradiation. The therapy was prescribed preoperatively most recently for 11 patients with rectal cancer. The authors used a radiofrequency system involving an endotract electrode with thermosensors for the hyperthermia. The effectiveness of preoperative HCR therapy was evaluated by irrigography, fiberscopy, and histopathologic findings in the resected specimens. Reduction in tumor size and amount was evident in all patients, with all modes of assessment. Histologically, no or only a few viable cancer cells were seen in the resected specimens in six patients, a small number of viable cancer cells in three, and a fair number of viable cancer cells in two patients; there were no complications. This method of treatment is expected to play an important role in the interdisciplinary treatment for rectal cancer.

AB - Preoperative hyperthermochemoradiotherapy (HCR therapy), consists of a combination of hyperthermia at 42 to 45°C for 40 minutes (2 times per week for two weeks), 5-fluorouracil (5-FU) intravenously (total, 1000 to 1750 mg), and a total of 30 Gy irradiation. The therapy was prescribed preoperatively most recently for 11 patients with rectal cancer. The authors used a radiofrequency system involving an endotract electrode with thermosensors for the hyperthermia. The effectiveness of preoperative HCR therapy was evaluated by irrigography, fiberscopy, and histopathologic findings in the resected specimens. Reduction in tumor size and amount was evident in all patients, with all modes of assessment. Histologically, no or only a few viable cancer cells were seen in the resected specimens in six patients, a small number of viable cancer cells in three, and a fair number of viable cancer cells in two patients; there were no complications. This method of treatment is expected to play an important role in the interdisciplinary treatment for rectal cancer.

UR - http://www.scopus.com/inward/record.url?scp=0024577789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024577789&partnerID=8YFLogxK

U2 - 10.1007/BF02553487

DO - 10.1007/BF02553487

M3 - Article

C2 - 2924671

AN - SCOPUS:0024577789

VL - 32

SP - 316

EP - 322

JO - Diseases of the Colon and Rectum

JF - Diseases of the Colon and Rectum

SN - 0012-3706

IS - 4

ER -